VPM2001
Cytomegalovirus (CMV) Prevention
Clinical (Phase not specified)Active
Key Facts
Indication
Cytomegalovirus (CMV) Prevention
Phase
Clinical (Phase not specified)
Status
Active
Company
About Serum Life Science Europe
Serum Life Science Europe GmbH is a specialized consultancy and service provider for biopharmaceutical development, with deep expertise in vaccines and biologics. Originally founded as Vakzine Projekt Management GmbH with German federal support, the company now operates as an independent entity majority-owned by the Serum Institute of India (SIIPL). SLS Europe generates revenue through client services while advancing its own pipeline of three main clinical-stage assets, including a novel tuberculosis vaccine candidate.
View full company profileTherapeutic Areas
Other Cytomegalovirus (CMV) Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| mRNA-1647 & mRNA-1230 | Moderna | Phase 3 |